EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Population Pharmacokinetic Analysis of Perampanel in Portuguese Patients Diagnosed with Refractory Epilepsy

Rui Silva iD, Helena Colom, Joana Bicker iD, Anabela Almeida iD, Ana Silva, Francisco Sales, Isabel Santana, Amílcar Falcão iD, Ana Fortuna iD

Pharmaceutics · 10.06.2023 · 15 (6) · 1704

DOI: 10.3390/pharmaceutics15061704 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 10.06.2023. Verfasst von Rui Silva und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pharmacology, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FEDER funds, Fundação para a Ciência e Tecnologia (FCT), Portuguese Agency for Scientific Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Perampanel is a promising antiepileptic drug (AED) for refractory epilepsy treatment due to its innovative mechanism of action. This study aimed to develop a population pharmacokinetic (PopPK) model to be further used in initial dose optimization of perampanel in patients diagnosed with refractory epilepsy. A total of seventy-two plasma concentrations of perampanel obtained from forty-four patients were analyzed through a population pharmacokinetic approach by means of nonlinear mixed effects modeling (NONMEM). A one-compartment model with first-order elimination best described the pharmacokinetic profiles of perampanel. Interpatient variability (IPV) was entered on clearance (CL), while the residual error (RE) was modeled as proportional. The presence of enzyme-inducing AEDs (EIAEDs) and body mass index (BMI) were found as significant covariates for CL and volume of distribution (V), respectively. The mean (relative standard error) estimates for CL and V of the final model were 0.419 L/h (5.56%) and 29.50 (6.41%), respectively. IPV was 30.84% and the proportional RE was 6.44%. Internal validation demonstrated an acceptable predictive performance of the final model. A reliable population pharmacokinetic model was successfully developed, and it is the first enrolling real-life adults diagnosed with refractory epilepsy.

Schlagwörter

Stichwörter der Autor:innen

NONMEMepilepsyperampanelpopulation pharmacokineticstherapeutic drug monitoring

Autor:innen und Institutionen

  • Laboratory of Pharmacology, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.
  • CIBIT/ICNAS-Coimbra Institute for Biomedical Imaging and Translational Research, University of Coimbra, 3000-548 Coimbra, Portugal.
  • Farmacoteràpia, Farmacogenètica i Tecnologia Farmacèutica, IDIBELL-Institut d'Investigació Biomèdica de Bellvitge, 08907 Hospitalet de Llobregat, Spain.
  • Pharmacy and Pharmaceutical Technology and Physical Chemistry Department, Universitat de Barcelona, 08028 Barcelona, Spain.
  • CIVG-Vasco da Gama Research Center, EUVG-Vasco da Gama University School, 3020-210 Coimbra, Portugal.
  • Refractory Epilepsy Reference Centre, Centro Hospitalar e Universitário de Coimbra, EPE, 3004-561 Coimbra, Portugal.

ORCID-Profile: Rui Silva, Joana Bicker, Anabela Almeida, Amílcar Falcão, Ana Fortuna

Förderung

  • FEDER funds
  • Fundação para a Ciência e Tecnologia (FCT), Portuguese Agency for Scientific Research

Zitieren

APA

Silva, R., Colom, H., Bicker, J., Almeida, A., Silva, A., Sales, F., Santana, I., Falcão, A., & Fortuna, A. (2023). Population Pharmacokinetic Analysis of Perampanel in Portuguese Patients Diagnosed with Refractory Epilepsy. Pharmaceutics, 15(6), 1704. https://doi.org/10.3390/pharmaceutics15061704

Vancouver

Silva R, Colom H, Bicker J, Almeida A, Silva A, Sales F, et al. Population Pharmacokinetic Analysis of Perampanel in Portuguese Patients Diagnosed with Refractory Epilepsy. Pharmaceutics. 2023;15(6):1704. doi:10.3390/pharmaceutics15061704

BibTeX
@article{Silva2023,
  author = {Silva, Rui and Colom, Helena and Bicker, Joana and Almeida, Anabela and Silva, Ana and Sales, Francisco and Santana, Isabel and Falcão, Amílcar and Fortuna, Ana},
  title = {Population Pharmacokinetic Analysis of Perampanel in Portuguese Patients Diagnosed with Refractory Epilepsy},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {6},
  pages = {1704},
  doi = {10.3390/pharmaceutics15061704}
}
Kostenlos starten →